These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Rivas JL, Palencia T, Fernández G, García M. Front Immunol; 2018 Feb 21; 9():1028. PubMed ID: 29867995 [Abstract] [Full Text] [Related]
10. Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients. Nguyen T, Staines D, Nilius B, Smith P, Marshall-Gradisnik S. Biol Res; 2016 May 31; 49(1):27. PubMed ID: 27245705 [Abstract] [Full Text] [Related]
11. Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients. Balinas C, Cabanas H, Staines D, Marshall-Gradisnik S. J Transl Med; 2019 Dec 03; 17(1):401. PubMed ID: 31796045 [Abstract] [Full Text] [Related]
13. A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis. Brenu EW, Broadley S, Nguyen T, Johnston S, Ramos S, Staines D, Marshall-Gradisnik S. J Immunol Res; 2016 Dec 03; 2016():9064529. PubMed ID: 26881265 [Abstract] [Full Text] [Related]
14. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Cliff JM, King EC, Lee JS, Sepúlveda N, Wolf AS, Kingdon C, Bowman E, Dockrell HM, Nacul L, Lacerda E, Riley EM. Front Immunol; 2019 Dec 03; 10():796. PubMed ID: 31057538 [Abstract] [Full Text] [Related]
15. Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study. Mensah F, Bansal A, Berkovitz S, Sharma A, Reddy V, Leandro MJ, Cambridge G. Clin Exp Immunol; 2016 May 03; 184(2):237-47. PubMed ID: 26646713 [Abstract] [Full Text] [Related]
16. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients. Nguyen T, Johnston S, Chacko A, Gibson D, Cepon J, Smith P, Staines D, Marshall-Gradisnik S. Asian Pac J Allergy Immunol; 2017 Jun 03; 35(2):75-81. PubMed ID: 27362406 [Abstract] [Full Text] [Related]
17. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery. Gómez-Mora E, Carrillo J, Urrea V, Rigau J, Alegre J, Cabrera C, Oltra E, Castro-Marrero J, Blanco J. Front Immunol; 2020 Jun 03; 11():582330. PubMed ID: 33329554 [Abstract] [Full Text] [Related]
18. Immunological abnormalities in patients with chronic fatigue syndrome. Tirelli U, Marotta G, Improta S, Pinto A. Scand J Immunol; 1994 Dec 03; 40(6):601-8. PubMed ID: 7997849 [Abstract] [Full Text] [Related]
19. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis. Brenu EW, van Driel ML, Staines DR, Ashton KJ, Hardcastle SL, Keane J, Tajouri L, Peterson D, Ramos SB, Marshall-Gradisnik SM. J Transl Med; 2012 May 09; 10():88. PubMed ID: 22571715 [Abstract] [Full Text] [Related]
20. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. Mandarano AH, Maya J, Giloteaux L, Peterson DL, Maynard M, Gottschalk CG, Hanson MR. J Clin Invest; 2020 Mar 02; 130(3):1491-1505. PubMed ID: 31830003 [Abstract] [Full Text] [Related] Page: [Next] [New Search]